Ling Xu, Yue Xuan Wang, Wei Wang, Xue Fan, Xue Yu Chen, Tian Yun Zhou, Yu He Liu, Ye Yu, Fan Yang, Zhen Yu Ju, Yong Zhou, Deng Liang Wang
{"title":"Association of Human Whole-blood NAD <sup>+</sup> Levels with Nabothian Cyst.","authors":"Ling Xu, Yue Xuan Wang, Wei Wang, Xue Fan, Xue Yu Chen, Tian Yun Zhou, Yu He Liu, Ye Yu, Fan Yang, Zhen Yu Ju, Yong Zhou, Deng Liang Wang","doi":"10.3967/bes2024.052","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Little is known about the association between whole-blood nicotinamide adenine dinucleotide (NAD <sup>+</sup>) levels and nabothian cysts. This study aimed to assess the association between NAD <sup>+</sup> levels and nabothian cysts in healthy Chinese women.</p><p><strong>Methods: </strong>Multivariate logistic regression analysis was performed to analyze the association between NAD <sup>+</sup> levels and nabothian cysts.</p><p><strong>Results: </strong>The mean age was 43.0 ± 11.5 years, and the mean level of NAD <sup>+</sup> was 31.3 ± 5.3 μmol/L. Nabothian cysts occurred in 184 (27.7%) participants, with single and multiple cysts in 100 (15.0%) and 84 (12.6%) participants, respectively. The total nabothian cyst prevalence gradually decreased from 37.4% to 21.6% from Q1 to Q4 of NAD <sup>+</sup> and the prevalence of single and multiple nabothian cysts also decreased across the NAD <sup>+</sup> quartiles. As compared with the highest NAD <sup>+</sup> quartile (≥ 34.4 μmol/L), the adjusted odds ratios with 95% confidence interval of the NAD <sup>+</sup> Q1 was 1.89 (1.14-3.14) for total nabothian cysts. The risk of total and single nabothian cysts linearly decreased with increasing NAD <sup>+</sup> levels, while the risk of multiple nabothian cysts decreased more rapidly at NAD <sup>+</sup> levels of 28.0 to 35.0 μmol/L.</p><p><strong>Conclusion: </strong>Low NAD <sup>+</sup> levels were associated with an increased risk of total and multiple nabothian cysts.</p>","PeriodicalId":93903,"journal":{"name":"Biomedical and environmental sciences : BES","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical and environmental sciences : BES","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3967/bes2024.052","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Little is known about the association between whole-blood nicotinamide adenine dinucleotide (NAD +) levels and nabothian cysts. This study aimed to assess the association between NAD + levels and nabothian cysts in healthy Chinese women.
Methods: Multivariate logistic regression analysis was performed to analyze the association between NAD + levels and nabothian cysts.
Results: The mean age was 43.0 ± 11.5 years, and the mean level of NAD + was 31.3 ± 5.3 μmol/L. Nabothian cysts occurred in 184 (27.7%) participants, with single and multiple cysts in 100 (15.0%) and 84 (12.6%) participants, respectively. The total nabothian cyst prevalence gradually decreased from 37.4% to 21.6% from Q1 to Q4 of NAD + and the prevalence of single and multiple nabothian cysts also decreased across the NAD + quartiles. As compared with the highest NAD + quartile (≥ 34.4 μmol/L), the adjusted odds ratios with 95% confidence interval of the NAD + Q1 was 1.89 (1.14-3.14) for total nabothian cysts. The risk of total and single nabothian cysts linearly decreased with increasing NAD + levels, while the risk of multiple nabothian cysts decreased more rapidly at NAD + levels of 28.0 to 35.0 μmol/L.
Conclusion: Low NAD + levels were associated with an increased risk of total and multiple nabothian cysts.